United States · FDA National Drug Code directory
Adzenys XR-ODT
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70165-025_512c5af5-6bf8-ace1-e063-6394a90ad807
- Product NDC
- 70165-025
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Amphetamine
- Labeler
- Neos Therapeutics Brands, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20160216
- Source listing expiry
- 20271231
Source-listed ingredients
- AMPHETAMINE — 15.7 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 BLISTER PACK in 1 CARTON (70165-025-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 70165-025-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →